Status:
TERMINATED
Liver Regeneration
Lead Sponsor:
University Health Network, Toronto
Conditions:
Liver Diseases
Liver Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The liver is the only visceral organ with a tremendous capacity to regenerate. We don't yet understand how normal liver regeneration occurs (on a molecular level) or how to distinguish between normal ...
Detailed Description
New studies are demonstrating that rodent models of the liver and liver disease are inadequate. The human liver is quite different and needs to be studied directly. The cell expression of human liver ...
Eligibility Criteria
Inclusion
- willing and able to provide written informed consent
- No history of liver disease or dysfunction
Exclusion
- Patients who receive chemotherapy within the 6 weeks prior to their hepatectomy and/or would be started on active chemotherapy within the first 4 weeks post-hepatectomy.
- Patients requiring long-term anticoagulation
Key Trial Info
Start Date :
September 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 19 2019
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT03396705
Start Date
September 12 2017
End Date
March 19 2019
Last Update
April 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2C4